Identification of miR-29a as a novel biomarker for lumpy skin disease virus exposure in cattle

References

• Kumar N, Chander Y, Kumar R, et al. Isolation and characterization of lumpy skin disease virus from cattle in India. PLoS One. 2021;16(1):e0241022. doi: 10.1371/journal.pone.0241022
   PubMed Web of Science ®Google Scholar
• Kumar N, Tripathi BN. A serious skin virus epidemic sweeping through the Indian subcontinent is a threat to the livelihood of farmers. Virulence. 2022;13(1):1943–14. doi: 10.1080/21505594.2022.2141971
   PubMed Web of Science ®Google Scholar
• Tuppurainen E, Dietze K, Wolff J, et al. Review: vaccines and vaccination against lumpy skin disease. Vaccines (Basel). 2021;9(10):1136. doi: 10.3390/vaccines9101136
   PubMed Web of Science ®Google Scholar
• Tuppurainen ES, Lubinga JC, Stoltsz WH, et al. Mechanical transmission of lumpy skin disease virus by Rhipicephalus appendiculatus male ticks. Epidemiol Infect. 2013;141(2):425–30. doi: 10.1017/S0950268812000805
   PubMed Web of Science ®Google Scholar
• Tuppurainen ES, Oura CA. Review: lumpy skin disease: an emerging threat to Europe, the Middle East and Asia. Transbound Emerg Dis. 2012;59(1):40–8. doi: 10.1111/j.1865-1682.2011.01242.x
   PubMed Web of Science ®Google Scholar
• Kumar N, Barua S, Kumar R, et al. Evaluation of the safety, immunogenicity and efficacy of a new live-attenuated lumpy skin disease vaccine in India. Virulence. 2023;14(1):2190647. doi: 10.1080/21505594.2023.2190647
   PubMed Web of Science ®Google Scholar
• Kumar R, Chander Y, Verma A, et al. A novel HRM-based gap-qRT-PCR for identification and quantitation of the vaccine and field strain(s) of lumpy skin disease virus. J Immunol Methods. 2023;519:113521. doi: 10.1016/j.jim.2023.113521
   PubMed Web of Science ®Google Scholar
• WOAH. The first South Asia transboundary animal diseases coordination meeting for PPR, FMD and LSD. Organized by, World Organization for animal Health (WOAH) and Food and Agricultural Organization (FAO) of the United Nations from May 7-12, 2023. 2023;1–35.
   Google Scholar
• Tuppurainen E, Oura C. Lumpy skin disease: an African cattle disease getting closer to the EU. Vet Rec. 2014;175(12):300–301. doi: 10.1136/vr.g5808
   PubMed Web of Science ®Google Scholar
• Tuppurainen ES, Pearson CR, Bachanek-Bankowska K, et al. Characterization of sheep pox virus vaccine for cattle against lumpy skin disease virus. Antiviral Res. 2014;109:1–6. doi: 10.1016/j.antiviral.2014.06.009
   PubMed Web of Science ®Google Scholar
• Zhugunissov K, Bulatov Y, Orynbayev M, et al. Goatpox virus (G20-LKV) vaccine strain elicits a protective response in cattle against lumpy skin disease at challenge with lumpy skin disease virulent field strain in a comparative study. Vet Microbiol. 2020;245:108695. doi: 10.1016/j.vetmic.2020.108695
   PubMed Web of Science ®Google Scholar
• Zeng Y. Principles of micro-RNA production and maturation. Oncogene. 2006;25(46):6156–6162. doi: 10.1038/sj.onc.1209908
   PubMed Web of Science ®Google Scholar
• VA PS, Kumar N, Kumar N. Role of miRNA in regulating virus replication. Animal Gene. 2023;30:200162. doi: 10.1016/j.angen.2023.200162
   Google Scholar
• Wang G, Cheng T, Yuan H, et al. Tracing cellular interaction of circRNA-miRNA axis with Cu metal-organic framework supported DNA cascade assembly. Biosens Bioelectron. 2023;228:115226. doi: 10.1016/j.bios.2023.115226
   PubMed Web of Science ®Google Scholar
• Liao Z, Zheng R, Shao G. Mechanisms and application strategies of miRNA‑146a regulating inflammation and fibrosis at molecular and cellular levels (review). Int J Mol Med. 2023;51(1):51. doi: 10.3892/ijmm.2022.5210
   PubMed Web of Science ®Google Scholar
• Girigoswami K, Girigoswami A. A review on the role of nanosensors in detecting cellular miRNA expression in colorectal cancer. Endocrine, metabolic & immune disorders drug targets. Endocr Metab Immune Disord Drug Targets. 2021;21(1):12–26. doi: 10.2174/1871530320666200515115723
   PubMed Web of Science ®Google Scholar
• Zeng G, Wang Z, Huang Y, et al. Cellular and viral miRNA expression in polyomavirus BK infection. Transpl Infect Dis. 2019;21(5):e13159. doi: 10.1111/tid.13159
   PubMed Web of Science ®Google Scholar
• Li J, Li X, Kong X, et al. MiRNA-26b inhibits cellular proliferation by targeting CDK8 in breast cancer. Int J Clin Exp Med. 2014;7:558–565.
   PubMed Web of Science ®Google Scholar
• Bernier A, Sagan SM. The diverse roles of microRnas at the host–virus interface. Viruses. 2018;10(8):440. doi: 10.3390/v10080440
   PubMed Web of Science ®Google Scholar
• Condrat CE, Thompson DC, Barbu MG, et al. miRnas as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis. Cells. 2020;9(2):276. doi: 10.3390/cells9020276
   PubMed Web of Science ®Google Scholar
• Babar IA, Slack FJ, Weidhaas JB. miRNA modulation of the cellular stress response. Future Oncol. 2008;4:289–298. doi: 10.2217/14796694.4.2.289
   PubMed Web of Science ®Google Scholar
• Boss IW, Renne R. Viral miRNAs: tools for immune evasion. Curr Opin Microbiol. 2010;13(4):540–545. doi: 10.1016/j.mib.2010.05.017
   PubMed Web of Science ®Google Scholar
• Momen‐Heravi F, Bala S. miRNA regulation of innate immunity. J Leukoc Biol. 2018;103:1205–1217. doi: 10.1002/JLB.3MIR1117-459R
   Web of Science ®Google Scholar
• Aslani M, Mortazavi-Jahromi SS, Mirshafiey A. Cytokine storm in the pathophysiology of COVID-19: possible functional disturbances of miRnas. Int Immunopharmacol. 2021;101:108172. doi: 10.1016/j.intimp.2021.108172
   PubMed Web of Science ®Google Scholar
• Sullivan CS, Grundhoff AT, Tevethia S, et al. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature. 2005;435(7042):682–686. doi: 10.1038/nature03576
   PubMed Web of Science ®Google Scholar
• Kumar N, Barua S, Thachamvally R, et al. Systems perspective of morbillivirus replication. J Mol Microbiol Biotechnol. 2016;26(6):389–400. doi: 10.1159/000448842
   PubMed Web of Science ®Google Scholar
• Pandita S, Verma A, Kamboj H, et al. miRNA profiling of primary lamb testicle cells infected with lumpy skin disease virus. Arch Virol. 2023;168(12):290. doi: 10.1007/s00705-023-05917-0
   PubMed Web of Science ®Google Scholar
• Dao TD, Tran LH, Nguyen HD, et al. Characterization of lumpy skin disease virus isolated from a giraffe in Vietnam. Transbound Emerg Dis. 2022;69(5):e3268–e3272. doi: 10.1111/tbed.14583
   PubMed Web of Science ®Google Scholar
• Greth A, Gourreau JM, Vassart M, et al. Capripoxvirus disease in an Arabian oryx (Oryx leucoryx) from Saudi Arabia. J Wildl Dis. 1992;28(2):295–300. doi: 10.7589/0090-3558-28.2.295
   PubMed Web of Science ®Google Scholar
• Hedger RS, Hamblin C. Neutralising antibodies to lumpy skin disease virus in African wildlife. Comp Immunol Microbiol Infect Dis. 1983;6(3):209–213. doi: 10.1016/0147-9571(83)90012-7
   PubMed Web of Science ®Google Scholar
• Fagbo S, Coetzer JA, Venter EH. Seroprevalence of rift valley fever and lumpy skin disease in African buffalo (syncerus caffer) in the Kruger National Park and Hluhluwe-IMfolozi park, South Africa. J S Afr Vet Assoc. 2014;85:e1–e7. doi: 10.4102/jsava.v85i1.1075
   PubMed Web of Science ®Google Scholar
• Kiplagat SK, Kitala PM, Onono JO, et al. Risk factors for outbreaks of lumpy skin disease and the Economic Impact in Cattle Farms of Nakuru County, Kenya. Front Vet Sci. 2020;7:259. doi: 10.3389/fvets.2020.00259
   PubMed Web of Science ®Google Scholar
• Abera Z, Degefu H, Gari G, et al. Sero-prevalence of lumpy skin disease in selected districts of West Wollega zone, Ethiopia. BMC Vet Res. 2015;11(1):135. doi: 10.1186/s12917-015-0432-7
   PubMedGoogle Scholar
• Khalafalla AI, Gaffar Elamin MA, Abbas Z. Récentes épidémies de dermatose nodulaire contagieuse bovine observées au Soudan. Rev Elev Med Vet Pays Trop. 1993;46(4):548–550. doi: 10.19182/remvt.9408
   PubMedGoogle Scholar
• Tang Q, Y-Q W, Chen D-S, et al. Bovine herpesvirus 5 encodes a unique pattern of microRNAs compared with bovine herpesvirus 1. J Gen Virol. 2014;95(3):671–678. doi: 10.1099/vir.0.061093-0
   PubMedGoogle Scholar
• Tian F, Luo J, Zhang H, et al. MiRNA expression signatures induced by Marek’s disease virus infection in chickens. Genomics. 2012;99:152–915. doi: 10.1016/j.ygeno.2011.11.004
   PubMed Web of Science ®Google Scholar
• Bao S, Jia L, Zhou X, et al. Integrated analysis of mRNA-seq and miRNA-seq for host susceptibilities to influenza a (H7N9) infection in inbred mouse lines. Funct Integr Genomics. 2018;18(4):411–424. doi: 10.1007/s10142-018-0602-3
   PubMed Web of Science ®Google Scholar
• Kaufmann SH, Dorhoi A, Hotchkiss RS, et al. Host-directed therapies for bacterial and viral infections. Nat Rev Drug Discov. 2018;17:35–56. doi: 10.1038/nrd.2017.162
   PubMed Web of Science ®Google Scholar
• Gari G, Abie G, Gizaw D, et al. Evaluation of the safety, immunogenicity and efficacy of three capripoxvirus vaccine strains against lumpy skin disease virus. Vaccine. 2015;33(28):3256–3261. doi: 10.1016/j.vaccine.2015.01.035
   PubMed Web of Science ®Google Scholar
• Kumar N, Wadhwa A, Chaubey KK, et al. Isolation and phylogenetic analysis of an orf virus from sheep in Makhdoom, India. Vir Gen. 2014;48(2):312–319. doi: 10.1007/s11262-013-1025-9
   PubMed Web of Science ®Google Scholar
• Khandelwal N, Chander Y, Rawat KD, et al. Emetine inhibits replication of RNA and DNA viruses without generating drug-resistant virus variants. Antiviral Res. 2017;144:196–204. doi: 10.1016/j.antiviral.2017.06.006
   PubMed Web of Science ®Google Scholar
• ND W The role of cell-mediated immunity in the pathogenesis of experimental lumpy skin disease virus Ph D Thesis submitted to School of Veterinary Medicine and Sciences, University of Surrey 2022.
   Google Scholar
• Abu-Izneid T, AlHajri N, Ibrahim AM, et al. Micro-RNAs in the regulation of immune response against SARS CoV-2 and other viral infections. J Adv Res. 2021;30:133–45. doi: 10.1016/j.jare.2020.11.013
   PubMed Web of Science ®Google Scholar
• Ostrycharz E, Hukowska-Szematowicz B. Micro-players of great significance—Host microRNA signature in Viral infections in Humans and animals. Int J Mol Sci. 2022;23(18):23. doi: 10.3390/ijms231810536
   Web of Science ®Google Scholar
• Yang X, Liang Y, Bamunuarachchi G, et al. miR-29a is a negative regulator of influenza virus infection through targeting of the frizzled 5 receptor. Arch Virol. 2021;166(2):363–73. doi: 10.1007/s00705-020-04877-z
   PubMed Web of Science ®Google Scholar
• Monteleone K, Selvaggi C, Cacciotti G, et al. MicroRNA-29 family expression and its relation to antiviral immune response and viro-immunological markers in HIV-1-infected patients. BMC Infect Dis. 2015;15(1):51. doi: 10.1186/s12879-015-0768-4
   PubMedGoogle Scholar
• Kumar N, Sharma S, Kumar R, et al. Host-directed antiviral therapy. Clin Microbiol Rev. 2020;33(3). doi: 10.1128/CMR.00168-19
   PubMed Web of Science ®Google Scholar
• Kumar R, Godara B, Chander Y, et al. Evidence of lumpy skin disease virus infection in camels. Acta Trop. 2023;242:106922. doi: 10.1016/j.actatropica.2023.106922
   PubMed Web of Science ®Google Scholar
• Woods JA. Lumpy skin disease—A review. Trop Anim Health Prod. 1988;20(1):11–17. doi: 10.1007/BF02239636
   PubMed Web of Science ®Google Scholar
• Haralambieva IH, Kennedy RB, Simon WL, et al. Differential miRNA expression in B cells is associated with inter-individual differences in humoral immune response to measles vaccination. PloS One. 2018;13(1):e0191812. doi: 10.1371/journal.pone.0191812
   PubMed Web of Science ®Google Scholar
• Coenen M, Hinze AV, Mengel M, et al. Immune- and miRNA-response to recombinant interferon beta-1a: a biomarker evaluation study to guide the development of novel type I interferon- based therapies. BMC Pharmacol Toxicol. 2015;16(1):25. doi: 10.1186/s40360-015-0025-x
   PubMedGoogle Scholar
• Kim JK, Kim TS, Basu J, et al. MicroRNA in innate immunity and autophagy during mycobacterial infection. Cell Microbiol. 2017;19(1):e12687. doi: 10.1111/cmi.12687
   Web of Science ®Google Scholar
• Ndzi EN, Nkenfou CN, Mekue LM, et al. MicroRNA hsa-miR-29a-3p is a plasma biomarker for the differential diagnosis and monitoring of tuberculosis. Tuberculosis. 2019;114:69–76. doi: 10.1016/j.tube.2018.12.001
   PubMed Web of Science ®Google Scholar
• Ma F, Xu S, Liu X, et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ. Nat Immunol. 2011;12(9):861–869. doi: 10.1038/ni.2073
   PubMed Web of Science ®Google Scholar
• Steiner DF, Thomas MF, Hu JK, et al. MicroRNA-29 regulates T-box transcription factors and interferon-γ production in helper T cells. Immunity. 2011;35(2):169–181. doi: 10.1016/j.immuni.2011.07.009
   PubMed Web of Science ®Google Scholar
• Savan R. Post-transcriptional regulation of interferons and their signaling pathways. J Interferon Cytokine Res. 2014;34(5):318–329. doi: 10.1089/jir.2013.0117
   PubMed Web of Science ®Google Scholar
• Fay PC, Wijesiriwardana N, Munyanduki H, et al. The immune response to lumpy skin disease virus in cattle is influenced by inoculation route. Front Immunol. 2022;13:1051008. doi: 10.3389/fimmu.2022.1051008
   PubMedGoogle Scholar
• HI WN, Sanz-Bernardo B, Graham S, et al. Characterising the cell-mediated immune response to lumpy skin disease virus. Access Microbiol. 2019;1(1A):1. doi: 10.1099/acmi.ac2019.po0289
   Google Scholar
• KH AM, Moustafa A, Saad MA. Evaluation of humoral and Cell-mediated immunity of lumpy skin disease vaccine prepared from local strainin calves and its related to maternal immunity. J Am Sci. 2016;12:38–45.
   Google Scholar
• Schmidt ME, Varga SM. The CD8 T cell response to respiratory virus infections. Front Immunol. 2018;9:678. doi: 10.3389/fimmu.2018.00678
   PubMed Web of Science ®Google Scholar
• Wherry EJ, Ahmed R. Memory CD8 T-cell differentiation during viral infection. J Virol. 2004;78(11):5535–5545. doi: 10.1128/JVI.78.11.5535-5545.2004
   PubMed Web of Science ®Google Scholar
• Doherty PC, Topham DJ, Tripp RA, et al. Effector CD4 + and CD8 + T-cell mechanisms in the control of respiratory virus infections. Immunol Rev. 1997;159(1):105–117. doi: 10.1111/j.1600-065X.1997.tb01010.x
   PubMedGoogle Scholar
• Goulding J, Abboud G, Tahiliani V, et al. CD8 T cells use IFN-γ to protect against the lethal effects of a respiratory poxvirus infection. J Immunol. 2014;192(11):5415–5425. doi: 10.4049/jimmunol.1400256
   PubMed Web of Science ®Google Scholar
• Andersen MH, Schrama D, Thor Straten P, et al. Cytotoxic T cells. J Invest Dermatol. 2006;126(1):32–41. doi: 10.1038/sj.jid.5700001
   PubMed Web of Science ®Google Scholar
• Chisari FV. Cytotoxic T cells and viral hepatitis. J Clin Investig. 1997;99(7):1472–1477. doi: 10.1172/JCI119308
   PubMed Web of Science ®Google Scholar
• Tokić S, Štefanić M, Glavaš-Obrovac L, et al. miR-29a-3p/T-bet regulatory circuit is altered in T cells of patients with Hashimoto’s thyroiditis. Front Endocrinol (Lausanne). 2018;9:264. doi: 10.3389/fendo.2018.00264
   PubMed Web of Science ®Google Scholar
• Wu H, Neilson JR, Kumar P, et al. miRNA profiling of Naïve, effector and memory CD8 T cells. PloS One. 2007;2(10):e1020. doi: 10.1371/journal.pone.0001020
   PubMed Web of Science ®Google Scholar
• Stelekati E, Cai Z, Manne S, et al. MicroRNA-29a attenuates CD8 T cell exhaustion and induces memory-like CD8 T cells during chronic infection. Proc Natl Acad Sci, USA. 2022;119(17):e2106083119. doi: 10.1073/pnas.2106083119
   PubMed Web of Science ®Google Scholar
• Haegeman A, De Leeuw I, Mostin L, et al. Duration of immunity induced after Vaccination of Cattle with a live attenuated or inactivated lumpy skin disease virus vaccine. Microorganisms. 2023;11(1):11. doi: 10.3390/microorganisms11010210
   Web of Science ®Google Scholar
• Rosca A, Anton G, Botezatu A, et al. miR‐29a associates with viro‐immunological markers of HIV infection in treatment experienced patients. J Med Virol. 2016;88(12):2132–7. doi: 10.1002/jmv.24586
   PubMed Web of Science ®Google Scholar
• MacOwan K. Observations on the epizootiology of lumpy skin disease during the first year of its occurrence in Kenya. Bull Epizootic Dis Afr. 1959;7:7–20.
   Google Scholar
• BM FM, Buchanan DS, Theunissen B, et al. On the history of cattle genetic resources. Diversity. 2014;6(4):705–750. doi: 10.3390/d6040705
   Google Scholar
• Wakchaure RG, Ahmad P, Kumar P, et al. Development of crossbred cattle in India: a review. Int J Emerging Technol Adv Eng. 2015;5:75.
   Google Scholar